Taltirelin tablets exhibit efficacy in the management of ataxia, a disorder characterized by irregular muscle movements. Each tablet comprises 5 mg of taltirelin hydrate, a compound structurally and functionally akin to the thyrotropin-releasing hormone. This hormone plays a vital role in safeguarding the body against conditions like depression, memory impairment, motor irregularities, and loss of consciousness. Nonetheless, due to its rapid metabolism, the hormone's direct effects are short-lived. Taltirelin hydrate serves as a mimetic agent, boasting a duration of action eight times longer than the hormone it emulates. Its attributes encompass the promotion of neurotransmitter release within the brain and functioning as a stimulator for nerve growth.
Taltirelin tablets are prescribed for the treatment of ataxia stemming from spinocerebellar disease. This medication proves efficacious across various forms of spinocerebellar diseases, encompassing conditions like olivopontocerebellar atrophy or MSA. Its effectiveness lies in mitigating symptoms such as disrupted movement coordination, abnormal gait, speech alterations, and irregularities in eye movements.
Active principles: taltirelin hydrate
Amount: 28 tablets
Maker: Sawai Pharmaceutical Co. Ltd., Osaka, Japan
Indications: treatment of the following symptoms of ataxia caused by spinocerebellar disorder:
Take 1 tablet 2 times daily, after breakfast and dinner. Your doctor can adjust the dosage according to your age and symptoms.
Contraindications: do not use for children, pregnant or breastfeeding women.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.
